BioLineRx Ltd (BLRX)

[midastouch017]

Several hedge funds have recently added to or reduced their stakes in the stock. Sabby Management LLC purchased a new stake in BioLineRx during the first quarter worth $3,018,000.

Citadel Advisors LLC boosted its stake in BioLineRx by 443.4% in the first quarter. Citadel Advisors LLC now owns 105,986 shares of the biotechnology company’s stock worth $102,000 after buying an additional 86,481 shares in the last quarter.

Benchmark Capital Advisors boosted its stake in BioLineRx by 227.3% in the first quarter. Benchmark Capital Advisors now owns 144,000 shares of the biotechnology company’s stock worth $138,000 after buying an additional 100,000 shares in the last quarter.

KCG Holdings Inc. boosted its stake in BioLineRx by 715.9% in the first quarter. KCG Holdings Inc. now owns 175,156 shares of the biotechnology company’s stock worth $168,000 after buying an additional 153,687 shares in the last quarter.

Finally, Renaissance Technologies LLC purchased a new stake in BioLineRx during the first quarter worth $126,000. Institutional investors and hedge funds own 38.01% of the company’s stock.

https://www.thecerbatgem.com/2017/08/04/biolinerx-ltd-nasdaqblrx-receives-consensus-rating-of-buy-from-brokerages-updated-updated.html